Synergistic induction of 1,25,-dihydroxyvitamin D3-and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps

Seung Hyun Kim, Tae Sung Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Many anti-inflammatory agents are known to significantly enhance the terminal differentiation of some cancer cells such as leukemia cells. In this study, the effect of yomogin, a eudesmane sesquiterpene lactone isolated from Artemisia princeps with antiinflammatory activity, was investigated in human promyelocytic leukemia HL-60 cells. Yomogin by itself induced small increases in cell differentiation, with less than 19% of the cells attaining a differentiated phenotype. Importantly, yomogin synergistically enhanced differentiation of HL-60 cells in a dose-dependent manner when combined with either 5 nM 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] or 50 nM all-trans retinoic acid (all-trans RA). Cytofluorometric analysis and morphologic studies indicated that the combinations of yomogin and 1,25-(OH)2D3 stimulated differentiation to monocytes whereas the combinations of yomogin and all-trans RA stimulated differentiation to granulocytes. These results suggest that yomogin may be useful in combination with 1,25-(OH)2D3 or all-trans-RA in the differentiation therapy for myeloid leukemias.

Original languageEnglish
Pages (from-to)886-890
Number of pages5
JournalPlanta Medica
Volume68
Issue number10
DOIs
Publication statusPublished - 2002 Oct 1
Externally publishedYes

Fingerprint

Artemisia
calcitriol
Sesquiterpenes
Calcitriol
HL-60 Cells
retinoic acid
sesquiterpenoid lactones
Lactones
Tretinoin
leukemia
Leukemia
cells
anti-inflammatory agents
myeloid leukemia
Eudesmane Sesquiterpenes
Anti-Inflammatory Agents
granulocytes
anti-inflammatory activity
cell differentiation
monocytes

Keywords

  • 1,25-dihydroxyvitamin D
  • All-trans-retinoic acid
  • Cancer
  • Differentiation
  • Yomogin

ASJC Scopus subject areas

  • Plant Science
  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

@article{42f4b23a9c0146cf9792c70d9966d9d1,
title = "Synergistic induction of 1,25,-dihydroxyvitamin D3-and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps",
abstract = "Many anti-inflammatory agents are known to significantly enhance the terminal differentiation of some cancer cells such as leukemia cells. In this study, the effect of yomogin, a eudesmane sesquiterpene lactone isolated from Artemisia princeps with antiinflammatory activity, was investigated in human promyelocytic leukemia HL-60 cells. Yomogin by itself induced small increases in cell differentiation, with less than 19{\%} of the cells attaining a differentiated phenotype. Importantly, yomogin synergistically enhanced differentiation of HL-60 cells in a dose-dependent manner when combined with either 5 nM 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] or 50 nM all-trans retinoic acid (all-trans RA). Cytofluorometric analysis and morphologic studies indicated that the combinations of yomogin and 1,25-(OH)2D3 stimulated differentiation to monocytes whereas the combinations of yomogin and all-trans RA stimulated differentiation to granulocytes. These results suggest that yomogin may be useful in combination with 1,25-(OH)2D3 or all-trans-RA in the differentiation therapy for myeloid leukemias.",
keywords = "1,25-dihydroxyvitamin D, All-trans-retinoic acid, Cancer, Differentiation, Yomogin",
author = "Kim, {Seung Hyun} and Kim, {Tae Sung}",
year = "2002",
month = "10",
day = "1",
doi = "10.1055/s-2002-34937",
language = "English",
volume = "68",
pages = "886--890",
journal = "Planta Medica",
issn = "0032-0943",
publisher = "Georg Thieme Verlag",
number = "10",

}

TY - JOUR

T1 - Synergistic induction of 1,25,-dihydroxyvitamin D3-and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps

AU - Kim, Seung Hyun

AU - Kim, Tae Sung

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Many anti-inflammatory agents are known to significantly enhance the terminal differentiation of some cancer cells such as leukemia cells. In this study, the effect of yomogin, a eudesmane sesquiterpene lactone isolated from Artemisia princeps with antiinflammatory activity, was investigated in human promyelocytic leukemia HL-60 cells. Yomogin by itself induced small increases in cell differentiation, with less than 19% of the cells attaining a differentiated phenotype. Importantly, yomogin synergistically enhanced differentiation of HL-60 cells in a dose-dependent manner when combined with either 5 nM 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] or 50 nM all-trans retinoic acid (all-trans RA). Cytofluorometric analysis and morphologic studies indicated that the combinations of yomogin and 1,25-(OH)2D3 stimulated differentiation to monocytes whereas the combinations of yomogin and all-trans RA stimulated differentiation to granulocytes. These results suggest that yomogin may be useful in combination with 1,25-(OH)2D3 or all-trans-RA in the differentiation therapy for myeloid leukemias.

AB - Many anti-inflammatory agents are known to significantly enhance the terminal differentiation of some cancer cells such as leukemia cells. In this study, the effect of yomogin, a eudesmane sesquiterpene lactone isolated from Artemisia princeps with antiinflammatory activity, was investigated in human promyelocytic leukemia HL-60 cells. Yomogin by itself induced small increases in cell differentiation, with less than 19% of the cells attaining a differentiated phenotype. Importantly, yomogin synergistically enhanced differentiation of HL-60 cells in a dose-dependent manner when combined with either 5 nM 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] or 50 nM all-trans retinoic acid (all-trans RA). Cytofluorometric analysis and morphologic studies indicated that the combinations of yomogin and 1,25-(OH)2D3 stimulated differentiation to monocytes whereas the combinations of yomogin and all-trans RA stimulated differentiation to granulocytes. These results suggest that yomogin may be useful in combination with 1,25-(OH)2D3 or all-trans-RA in the differentiation therapy for myeloid leukemias.

KW - 1,25-dihydroxyvitamin D

KW - All-trans-retinoic acid

KW - Cancer

KW - Differentiation

KW - Yomogin

UR - http://www.scopus.com/inward/record.url?scp=0036774868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036774868&partnerID=8YFLogxK

U2 - 10.1055/s-2002-34937

DO - 10.1055/s-2002-34937

M3 - Article

VL - 68

SP - 886

EP - 890

JO - Planta Medica

JF - Planta Medica

SN - 0032-0943

IS - 10

ER -